Videos / Olopatadine hydrochloride & mometasone furoate combination nasal spray for allergic rhinitis & rhinoconjunctivitis
In this Product Explainer, Rhinologist Prof Richard Harvey explains the role of olopatadine hydrochloride and mometasone furoate combination nasal spray in the treatment of symptoms associated with allergic rhinitis and rhinoconjunctivitis in patients 6 years of age and older (5 mins).
This Product Explainer is supported by CSL Seqirus

The Peptide Craze – What You Need to Know

Managing Acute Heart Failure After Discharge: A Practical Guide for GPs

Oral Contraceptives on the PBS – A Practical Guide for GPs

The Impact of PFAS & Other Endocrine Disrupting Chemicals on Fertility

expert
Rhinologist; Nose, Sinus, Allergy and Endoscopic Sinus and Skull Base Surgeon, Macquarie University, St Vincent's Hospitals, Sydney; Program Head, Rhinology & Skull Base Surgery, Applied Medical Research Center, UNSW; Professor, UNSW, Macquarie University